Welcome to the era of mindful medicine.
Psilera Appoints Neuroscience Veteran
Allyson Gage, PhD
VP, Clinical Development
to Lead Upcoming Phase 1 Clinical Trial
Psilera
At A
Glance
-
We have created and developed six separate serotonergic compound families.
-
Two patents have been issued from the USPTO covering over 1 million novel compounds.
-
The Psilera leadership team has over 125 years of combined experience in the biotech and pharmaceutical industries.
-
Our best-in-class proprietary compound library has coverage for over 1 million novel compounds.
-
Psilera’s co-founders bring over $1.5B in cumulative value created from prior start-ups.
Psilera is revolutionizing how small molecule drug discovery is done. We pioneer & engineer novel therapies through next-generation precision neuroscience.
Our neuroplastogen focused pipeline offers a spectrum of solutions to meet the evolving needs of patients.
UPCOMING EVENTS
UPCOMING EVENTS
Sept. 15 - 17
Boston, MA
Neuropsychiatric Drug Development Summit
Chief Medical Officer Magali Haas, MD-PhD, to speak at the 9th Annual Neuropsychiatric Drug Development Summit. Her panel discussion, “To What Degree Does Neuroplasticity Underpin Psychedelics Efficacy?” will explore neuroplasticity’s role in synaptic remodeling. She will be joined by co-founder and CSO Dr. Jackie von Salm to discuss our latest data with fellow innovators in the field. If you will be in Boston for the event and would like to connect, message us at info@psilera.com.
Philadelphia, PA
Oct. 8 - 11
International Conference on Frontotemporal Dementias
In the fall, EVP of Corporate Development Scott Rairigh and Chief Medical Officer Magali Haas, MD-PhD, will connect with key researchers and advocacy leaders at the International Society for Frontotemporal Dementias’s (ISFTD) 15th annual International Conference on Frontotemporal Dementias. If you will be in Philadelphia for the event and would like to learn more about the future of neurodegenerative care, message us at info@psilera.com.
Oct. 10
Orlando, FL
FL Innovation Conference
The Florida Innovation Conference, powered by BioFL, is designed to showcase the exciting companies helping shape Florida’s life sciences ecosystem. Dr. Jackie von Salm will be featured as an “Innovation Spotlight” speaker, highlighting Psilera's innovative work to establish Florida as a destination for biopharmaceutical development.
Oct. 29 - 30
Fitchburg, WI
UW-Madison Psychedelic Symposium
The UW-Madison Psychedelic Symposium, hosted at Usona Institute, brings together researchers, graduate students, and key industry stakeholders to share their latest research and facilitate collaboration in this dynamic, evolving field. Scott Rarigh will be attending to share the latest innovations from Psilera Labs.
Nov. 16 - 19
London
Jefferies Global Healthcare Week
Co-Founders Chris Witowski, PhD, and Jackie von Salm, PhD, will travel across the pond to meet with key development partners and investors from throughout Europe. Their focus while in London is to further the PSIL-006 clinical program through focused discussions with new and established pharmaceutical connections. If you will be in London for the event and would like to learn more, message us at info@psilera.com.
Jan. 10
San Francisco, CA
Neuroscience Innovation Forum
Co-Founders Chris Witowski, PhD, and Jackie von Salm, PhD, will be speaking and presenting at the 10th annual Neuroscience Innovation Forum. Dr. von Salm will share her unique perspective on the Psychedelics 2027 Panel: Where Does the Field Stand. Dr. Witowski will be sharing the latest development from Psilera via a company presentation.